(98 days)
Not Found
No
The summary describes a root canal filling material and its physical properties and performance, with no mention of AI or ML.
Yes.
CeraSeal is used for permanent obturation (filling) of the root canal after pulp removal, which is a therapeutic intervention aimed at treating the root canal.
No
The device description states its purpose is for "root canal filling" and "permanent obturation of the root canal," which are therapeutic treatments, not diagnostic processes.
No
The device description clearly states it is a "flowable paste" and a "material," indicating it is a physical substance used for root canal filling, not software.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections. They are used to provide information for diagnosis, monitoring, or screening.
- Device Function: The provided description clearly states that CeraSeal is a material used for filling root canals after the removal of infected pulp tissue. It is a physical material applied directly to an anatomical site (the root canal) within the body.
- Intended Use: The intended use is for the permanent obturation (filling) of the root canal. This is a therapeutic procedure, not a diagnostic test performed on a sample outside the body.
- Device Description: The description details the physical form (flowable paste), application method (using a disposable tip), and curing process (by absorbing ambient water). These are characteristics of a medical device used for treatment, not an IVD.
- Lack of Diagnostic Elements: There is no mention of analyzing a sample, detecting biomarkers, or providing diagnostic information based on a test performed on a bodily fluid or tissue sample.
In summary, CeraSeal is a dental material used for a therapeutic procedure (root canal filling), not a diagnostic test performed in vitro.
N/A
Intended Use / Indications for Use
- Permanent obturation of the root canal following vital pulp-extirpation
- Permanent obturation of the root canal following removal of infected or necrotic pulp and placement of intracanal dressings
CeraSeal is suitable for use in the single cone and lateral condensation technique.
Product codes
KIF
Device Description
CeraSeal is used for root canal filling after the removal of infected pulp tissue in the root canal. CeraSeal is in the form of a flowable paste and can be immediately applied inside the root canal using a disposable tip. material, and a thickening agent. This product characteristically cures slowly by absorbing the ambient water inside the root canal. It is white and aesthetic.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
root canal
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Prescription / Hospital
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The following testing was conducted on our subject device:
- Biocompatibility Tests according to ISO 10993-1:2009, ISO 10993-5:2009, ISO 10993-10:2010, ISO 10993-11:2006.
- Performance tests such as visual, capacity, package, flow, setting time, film thickness, solubility . and radio-opacity according to ISO 6876:2012.
- Shelf Life test: ISO 6876 tests (extraneous matter, package, flow, setting time, film thickness and Solubility)
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 872.3820 Root canal filling resin.
(a)
Identification. A root canal filling resin is a device composed of material, such as methylmethacrylate, intended for use during endodontic therapy to fill the root canal of a tooth.(b)
Classification. (1) Class II if chloroform is not used as an ingredient in the device.(2) Class III if chloroform is used as an ingredient in the device.
(c)
Date PMA or notice of completion of a PDP is required. A PMA or a notice of completion of a PDP is required to be filed with the Food and Drug Administration on or before December 26, 1996 for any root canal filling resin described in paragraph (b)(2) of this section that was in commercial distribution before May 28, 1976, or that has, on or before December 26, 1996 been found to be substantially equivalent to a root canal filling resin described in paragraph (b)(2) of this section that was in commercial distribution before May 28, 1976. Any other root canal filling resin shall have an approved PMA or a declared completed PDP in effect before being placed in commercial distribution.
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo includes the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.
June 7, 2019
Meta Biomed Co., Ltd. % April Lee Consultant Withus Group Inc 106 Superior Irvine. California 92620
Re: K190503
Trade/Device Name: CeraSeal Regulation Number: 21 CFR 872.3820 Regulation Name: Root Canal Filling Resin Regulatory Class: Class II Product Code: KIF Dated: March 11, 2019 Received: March 19, 2019
Dear April Lee:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Srinivas Nandkumar, Ph.D. Assistant Director DHT1B: Division of Dental Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K190503
Device Name CeraSeal
Indications for Use (Describe)
· Permanent obturation of the root canal following vital pulp-extirpation
· Permanent obturation of the root canal following removal of infected or necrotic pulp and placement of intracanal dressings
CeraSeal is suitable for use in the single cone and lateral condensation technique.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the logo for Meta Biomed. The logo consists of a stylized tooth shape on the left, with the top half in dark blue and the bottom half in teal. To the right of the tooth shape are the words "META" in dark blue above the word "BIOMED" in teal. There is a registered trademark symbol next to the word META.
Address
270, Osongsaengmyeong 1-ro,
Osong-eup, Heungdeok-gu,
Cheongju-si, Chungcheongbuk-do,
Korea
Tel
+82-43-216-0433
Fax
+82-43-217-1988
META BIOMED CO.LTD.
E-mail
info@meta-biomed.com
http://www.meta-biomed.com
0(k) Summary
Submitter
META BIOMED CO., LTD. Suk Song Oh 270, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, South Korea Email: ef1459@metabiogw.bizmeka.com Phone: +82-43-230-8841 Fax: +82-43-217-1983
Official Correspondent
Withus Group Inc April Lee 106 Superior, Irvine, CA 92620 USA Email: withus6664@gmail.com Phone: 1-909-274-9971 Fax: 1-909-460-8122
Device Information
- Trade Name: CeraSeal
- . Classification Name: resin, root canal filling
- Product Code: KIF
- Panel: Dental
- Regulation Number: 21 CFR 872.3820
- Device Class: Class II
- Date prepared: 02/20/2019
Predicate Devices:
- K080917, iRoot SP manufactured by Innovative BioCeramix Inc.
Device Description
CeraSeal is used for root canal filling after the removal of infected pulp tissue in the root canal. CeraSeal is in the form of a flowable paste and can be immediately applied inside the root canal using a disposable tip. material, and a thickening agent. This product characteristically cures slowly by absorbing the ambient water inside the root canal. It is white and aesthetic.
Indication for Use
- Permanent obturation of the root canal following vital pulp-extirpation
- Permanent obturation of the root canal following removal of infected or necrotic pulp and placement of intracanal dressings
CeraSeal is suitable for use in the single cone and lateral condensation technique.
4
Image /page/4/Picture/0 description: The image shows the logo for Meta Biomed. The logo consists of a stylized tooth shape on the left, with the top half in dark blue and the bottom half in teal. To the right of the tooth shape, the words "META" and "BIOMED" are stacked on top of each other, also in teal. The "META" has a registered trademark symbol next to it.
Address
270, Osongsaengmyeong 1-ro,
Osong-eup, Heungdeok-gu,
Cheongju-si, Chungcheongbuk-do,
Korea
Tel
+82-43-216-0433
Fax
+82-43-217-1988
Non-clinical Testing
The following testing was conducted on our subject device:
- . Biocompatibility Tests according to ISO 10993-1:2009, ISO 10993-5:2009, ISO 10993-10:2010, ISO 10993-11:2006.
- Performance tests such as visual, capacity, package, flow, setting time, film thickness, solubility . and radio-opacity according to ISO 6876:2012.
- . Shelf Life test: ISO 6876 tests (extraneous matter, package, flow, setting time, film thickness and Solubility)
Summary of Technological Characteristics:
The subject device and the predicate device have the same intended use and have the similar technological characteristics and are made of similar materials. They encompass the same range of physical and chemical properties. The subject device and predicate devices are packaged in similar material and use similar methods of application.
The subject device is different from the predicate devices in raw materials, however, the test results provided in this submission supports that it is substantially equivalent to the predicate device.
| Subject Device | Predicate Device | |
|---|---|---|
| Manufacturer | Meta Biomed Co., Ltd. | Innovative BioCeramix, Inc. |
| Device Name | CeraSeal | iRoot SP |
| 510(k) Number | NA | K080917 |
| Classification Name | resin, root canal filling | resin, root canal filling |
| Product Code | KIF | KIF |
| Regulation Number | 21 CFR 872.3820 | 21 CFR 872.3820 |
| Indications for use | ● Permanent obturation of the root canal following vital pulp-extirpation | |
| ● Permanent obturation of the root canal following removal of infected or necrotic pulp and placement of intracanal dressings | ||
| CeraSeal is suitable for use in the single cone and lateral condensation technique. | ● Permanent obturation of the root canal following vital pulp-extirpation | |
| ● Permanent obturation of the root canal following removal of infected or necrotic pulp and placement of intracanal dressings | ||
| iRoot SP is suitable for use in the single cone and lateral condensation technique. |
5
Image /page/5/Picture/0 description: The image shows the logo for META BIOMED. The logo consists of a stylized tooth shape on the left, with the top half in dark blue and the bottom half in teal. To the right of the tooth shape is the text "META" in dark blue, with a registered trademark symbol above the A. Below "META" is the text "BIOMED" in teal.
Address 270, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Korea
+82-43-216-0433 Fax +82-43-217-1988
Tel
info@meta-biomed.com http://www.meta-biomed.com
| | Insoluble, radiopaque material based on a
calcium silicate compound containing: | Insoluble, radiopaque material based on a
calcium silicate compound containing: |
|-------------------------------------|------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| | Thickening agent | Thickening agent |
| Raw Material | Zirconium dioxide
Calcium silicates
1, 3 Propanediol | Zirconium oxide filler
Calcium silicates
Calcium phosphate monobasic
Calcium hydroxide |
| Principle of Operation | identical | iRoot SP is a convenient premixed ready-
to-use injectable white hydraulic cement
paste developed for permanent root canal
filling and sealing applications. iRoot SP
is an insoluble, radiopaque material
which requires the presence of water to
set and harden. iRoot SP is packaged in a
pre-loaded syringe and is supplied with
disposable tips. |
| Performance Standard
Conformance | Conformed to ISO 6876 | Conformed to ISO 6876 |
| Biocompatibility | Yes | Yes |
| Use | Prescription / Hospital | Prescription / Hospital |
| Delivery Forms | Single Paste | Single Paste |
| Sterility | Non-sterile | Non-sterile |
| Shelf Life | 2 years | 2 years |
Conclusion:
Based on documentation supplied with this submissions drawn from the testing results demonstrate that the subject device is substantially equivalent to our legally marketed predicate device.